PD-1/PD-L pathway inhibits M.tb-specific CD4⁺ T-cell functions and phagocytosis of macrophages in active tuberculosis.

ABSTRACT: The role of the PD-1/PD-L pathway in a murine model of tuberculosis remains controversial regarding viral infections and clinical tuberculosis. We conducted a case-control study to investigate the modulating role and mechanism of the PD-1/PD-L pathway in patients with active tuberculosis. Fifty-nine participants, including 43 active tuberculosis (ATB) patients and 16 healthy controls (HC), were enrolled. Cell surface staining and flow cytometry were used to detect the expressions of PD-1 and its ligands on T cells and monocytes. Intracellular cytokine staining was used to determine the PPD-specific IFN-?-secreting T-cell proportion. CD4⁺ T-cell proliferation and macrophage functions were investigated in the presence or absence of PD-1/PD-L pathway blockade. Proportions of both PD-1⁺CD4⁺ and PD-L1⁺CD4⁺ T cells in ATB patients were more significantly increased than in the HC group (P?=?0.0112 and P?=?0.0141, respectively). The expressions of PD-1, PD-L1, and PD-L2 on CD14⁺ monocytes in ATB patients were much higher than those in the HC group (P?=?0.0016, P?=?0.0001, and P?=?0.0088, respectively). Blockade of PD-1 could significantly enhance CD4⁺ T-cell proliferation (P?=?0.0433). Phagocytosis and intracellular killing activity of macrophages increased significantly with PD-1/PD-L pathway blockade. In conclusion, the PD-1/PD-L pathway inhibits not only M.tb-specific CD4⁺ T-cell-mediated immunity but also innate immunity.

SUBMITTER: Shen L 

PROVIDER: S-EPMC5141449 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature